Details of Regulatory Actions
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received three separate drug license suspension orders from state drug control authorities:
1. Hubli, Karnataka Store
- Authority: Assistant Director, Drugs Control Administration, Hubli Circle, Hubli Karnataka
- Action: Suspension of Drug License for one day
- Store Location: Adarsha Nagar Hubli, Karnataka
- Financial Impact: Potential revenue loss of ₹0.22 lakhs
2. Gadag, Karnataka Store
- Authority: Assistant Director, Drugs Control Administration, Gadag Circle, Gadag Karnataka
- Action: Suspension of Drug License for two days
- Store Location: Rani Road Gadag, Karnataka
- Date of Receipt: Order received on June 25, 2026
- Violation Cited: Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945
- Financial Impact: Potential revenue loss of ₹0.60 lakhs
3. Andhra Pradesh Store
- Authority: Assistant Director, Drugs Control Administration, Serilingampally Andhra Pradesh
- Action: Suspension of Drug License for three days
- Store Location: Radhakrishna Nagar Attapur Andhra Pradesh
- Financial Impact: Potential revenue loss of ₹0.76 lakhs
Total Financial Impact
The company estimates the total potential revenue loss across all three stores at ₹1.58 lakhs.
Additional Information
The disclosure will be available on the company's website (www.medplusindia.com) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Ltd. (www.nseindia.com).
Company Representation
The letter is signed by Gangadi Madhukar Reddy, Managing Director and Chief Executive Officer (DIN: 00098097) of MedPlus Health Services Limited.